ACTA1 and cancer: Because cancer-associated fibroblasts (CAFs) are known to express PD-L1 [52, 53] and to suppress CD8+ T-cells [53] we stained the tumors with alpha-smooth muscle actin (αSMA), a CAF marker, and observed that both lapatinib and MRTX849 treatment induced massive accumulation of CAFs.